Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement

D. K. Owens
K. W. Davidson, Zucker School of Medicine at Hofstra/Northwell
A. H. Krist
M. J. Barry
M. Cabana
A. B. Caughey
C. A. Doubeni
J. W. Epling
M. Kubik
C. S. Landefeld
C. M. Mangione
L. Pbert
M. Silverstein
M. A. Simon
C. W. Tseng
J. B. Wong

Abstract

© 2020 American Medical Association. All rights reserved. Importance: Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person's independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individuals in the United States, and its prevalence increases with age. Objective: To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a review of the evidence on screening for cognitive impairment, including mild cognitive impairment and mild to moderate dementia, in community-dwelling adults, including those 65 years or older residing in independent living facilities. Population: This recommendation applies to community-dwelling older adults 65 years or older, without recognized signs or symptoms of cognitive impairment. Evidence Assessment: The USPSTF concludes that the evidence is lacking, and the balance of benefits and harms of screening for cognitive impairment cannot be determined. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults. (I statement).